Assessment of galactose-1-phosphate uridyltransferase activity in cells and tissues
Galactosemias are a family of autosomal recessive genetic disorders resulting from impaired enzymes of the Leloir pathway of galactose metabolism including galactokinase, galactose uridyltransferase, and UDP-galactose 4-epimerase that are critical for conversion of galactose into glucose-6-phosphate. To better understand pathophysiological mechanisms involved in galactosemia and develop novel therapies to address the unmet need in patients, it is important to develop reliable assays to measure the activity of the Leloir pathway enzymes. Here we describe in-depth methods for indirectly measuring Galacose-1-Phosphate Uridyltransferase activity in cell culture and animal tissues.
1. Christacos NC, Fridovich-Keil JL. Impact of patient mutations on heterodimer formation and function in human galactose-1-P uridylyltransferase. Mol Genet Metab. 2002 Aug;76(4):319–26. https://doi.org/10.1016/S1096-7192(02)00109-9 PMID:12208137
2. Haskovic M, Coelho AI, Bierau J, Vanoevelen JM, Steinbusch LK, Zimmermann LJ, et al. Pathophysiology and targets for treatment in hereditary galactosemia: A systematic review of animal and cellular models. J Inherit Metab Dis. 2020 May;43(3):392–408. https://doi.org/10.1002/jimd.12202 PMID:31808946
3. Rubio-Gozalbo ME, Haskovic M, Bosch AM, Burnyte B, Coelho AI, Cassiman D, et al. The natural history of classic galactosemia: lessons from the GalNet registry. Orphanet J Rare Dis. 2019 Apr;14(1):86. https://doi.org/10.1186/s13023-019-1047-z PMID:31029175
4. Demirbas D, Coelho AI, Rubio-Gozalbo ME, Berry GT. Hereditary galactosemia. Metabolism. 2018 Jun;83:188–96. https://doi.org/10.1016/j.metabol.2018.01.025 PMID:29409891
5. Fujimoto A, Okano Y, Miyagi T, Isshiki G, Oura T. Quantitative Beutler test for newborn mass screening of galactosemia using a fluorometric microplate reader. Clin Chem. 2000 Jun;46(6 Pt 1):806–10. https://doi.org/10.1093/clinchem/46.6.806 PMID:10839768
6. Reichardt JK. Molecular analysis of 11 galactosemia patients. Nucleic Acids Res. 1991 Dec;19(25):7049–52. https://doi.org/10.1093/nar/19.25.7049 PMID:1766867
7. Fridovich-Keil JL, Jinks-Robertson S. A yeast expression system for human galactose-1-phosphate uridylyltransferase. Proc Natl Acad Sci USA. 1993 Jan;90(2):398–402. https://doi.org/10.1073/pnas.90.2.398 PMID:8421669
8. Cuthbert C, Klapper H, Elsas L. Diagnosis of inherited disorders of galactose metabolism. Curr Protoc Hum Genet. 2008 Jan;Chapter 17:Unit 17.5. https://doi.org/10.1002/0471142905.hg1705s56.. PMID: 18428423
9. Ring J, Osborne F, Shapiro J, Johnson R. Radioactive waste management at a large university and medical research complex. Health Phys. 1993 Aug;65(2):193–9. https://doi.org/10.1097/00004032-199308000-00011 PMID:8330967
10. Slepak TI, Tang M, Slepak VZ, Lai K. Involvement of endoplasmic reticulum stress in a novel Classic Galactosemia model. Mol Genet Metab. 2007 Sep-Oct;92(1-2):78–87. https://doi.org/10.1016/j.ymgme.2007.06.005 PMID:17643331
11. Christacos NC, Marson MJ, Wells L, Riehman K, Fridovich-Keil JL. Subcellular localization of galactose-1-phosphate uridylyltransferase in the yeast Saccharomyces cerevisiae. Mol Genet Metab. 2000 Aug;70(4):272–80. https://doi.org/10.1006/mgme.2000.3019 PMID:10993714
12. Pasquali M, Yu C, Coffee B. Laboratory diagnosis of galactosemia: a technical standard and guideline of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2018 Jan;20(1):3–11. https://doi.org/10.1038/gim.2017.172 PMID:29261178